Literature DB >> 22802312

How genetic variant libraries effectively extend gene testing patents: implications for intellectual property and good clinical care.

Sean McElligott1, Robert I Field, Mirar Bristol-Demeter, Susan M Domchek, David A Asch.   

Abstract

Mesh：

Year:  2012        PMID： 22802312      PMCID： PMC3417048          DOI： 10.1200/JCO.2012.42.7757

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  A full-likelihood method for the evaluation of causality of sequence variants from family data.

Authors:  Deborah Thompson; Douglas F Easton; David E Goldgar
Journal:  Am J Hum Genet       Date:  2003-07-29       Impact factor: 11.025

2.  Realizing genomic medicine.

Authors:  Elizabeth G Phimister; W Gregory Feero; Alan E Guttmacher
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

3.  The case for locus-specific databases.

Authors:  Mark E Samuels; Guy A Rouleau
Journal:  Nat Rev Genet       Date:  2011-05-04       Impact factor: 53.242

4.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

5.  The breast cancer information core: database design, structure, and scope.

Authors:  C Szabo; A Masiello; J F Ryan; L C Brody
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

6.  LOVD: easy creation of a locus-specific sequence variation database using an "LSDB-in-a-box" approach.

Authors:  Ivo F A C Fokkema; Johan T den Dunnen; Peter E M Taschner
Journal:  Hum Mutat       Date:  2005-08       Impact factor: 4.878

Review 7.  A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).

Authors:  Noralane M Lindor; Lucia Guidugli; Xianshu Wang; Maxime P Vallée; Alvaro N A Monteiro; Sean Tavtigian; David E Goldgar; Fergus J Couch
Journal:  Hum Mutat       Date:  2011-11-03       Impact factor: 4.878

8.  ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.

Authors:  Amanda B Spurdle; Sue Healey; Andrew Devereau; Frans B L Hogervorst; Alvaro N A Monteiro; Katherine L Nathanson; Paolo Radice; Dominique Stoppa-Lyonnet; Sean Tavtigian; Barbara Wappenschmidt; Fergus J Couch; David E Goldgar
Journal:  Hum Mutat       Date:  2011-11-03       Impact factor: 4.878

9.  Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.

Authors:  Andrew D Spearman; Kevin Sweet; Xiao-Ping Zhou; Jane McLennan; Fergus J Couch; Amanda Ewart Toland
Journal:  J Clin Oncol       Date:  2008-09-29       Impact factor: 44.544
  9 in total
  2 in total

1.  Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.

Authors:  Kenneth Offit; Angela Bradbury; Courtney Storm; Jon F Merz; Kevin E Noonan; Rebecca Spence
Journal:  J Clin Oncol       Date:  2013-06-13       Impact factor: 44.544

2.  Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.

Authors:  Derek So; Yann Joly
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.